Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.56−0.05 (-7.95%)
Close on Nov 17, 2026Market cap $59.56MP/E –Yield –
Hyperfine price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Hyperfine's price to sales ratio was 4.0× on Nov 11, 2026, against 7.7× a year earlier. Over the last 5 years it ranged from 3.8× to 51.8×, with a median of 7.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.0× | −3.1 |
| 2025 | Dec 31, 2025 | 7.1× | +2.3 |
| 2024 | Dec 31, 2024 | 4.8× | −3.4 |
| 2023 | Dec 29, 2023 | 8.1× | −14.5 |
| 2022 | Jan 31, 2022 | 22.7× | −14.9 |
| 2021 | Dec 31, 2021 | 37.6× | – |
See a number that looks wrong?